Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CB-5339 |
Synonyms | |
Therapy Description |
CB-5339 inhibits valosin-containing protein (VCP, p97), potentially resulting in decreased tumor cell viability and reduced tumor burden (PMID: 33790022). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CB-5339 | CB5339|CB 5339 | CB-5339 inhibits valosin-containing protein (VCP, p97), potentially resulting in decreased tumor cell viability and reduced tumor burden (PMID: 33790022). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04402541 | Phase I | CB-5339 | Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome | Completed | USA | AUS | 0 |